4//SEC Filing
ROE ROBERT L 4
Accession 0001209191-12-007499
CIK 0001088856other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:50 PM ET
Size
14.2 KB
Accession
0001209191-12-007499
Insider Transaction Report
Form 4
ROE ROBERT L
President and Secretary
Transactions
- Exercise/Conversion
Common stock
2012-02-01$1.19/sh+3,000$3,570→ 25,007 total - Exercise/Conversion
Common stock
2012-02-02$1.19/sh+7,000$8,330→ 19,007 total - Sale
Common stock
2012-02-01$3.53/sh−13,000$45,912→ 12,007 total - Sale
Common stock
2012-02-02$3.30/sh−7,000$23,109→ 12,007 total - Exercise/Conversion
Stock option
2012-02-01−3,000→ 187,000 totalExercise: $1.19Exp: 2019-03-26→ Common stock (3,000 underlying) - Exercise/Conversion
Stock option
2012-02-02−7,000→ 180,000 totalExercise: $1.19Exp: 2019-03-26→ Common stock (7,000 underlying)
Footnotes (4)
- [F1]The sale is made pursuant to terms of a 10b5-1 plan in effect at the time of sale of the shares.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $3.3627 to $3.60 per share. Full information on the numbers of shares sold at each sale price is available upon request.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $3.2945 to $3.31 per share. Full information on the numbers of shares sold at each sale price is available upon request.
- [F4]Fully exerciseable.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001286208
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:50 PM ET
- Size
- 14.2 KB